Pfizer, Serum or Bharat Biotech - whose Covid vaccine will be India's 1st?

In this podcast, we will talk about the Covid Vaccine scenario, in which we will discuss trial results, efficacy among other things

Kanishka Gupta New Delhi

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab

File

1 min read Last Updated : Dec 08 2020 | 12:49 PM IST

A senior government official informed on Monday that India is considering reviewing Pfizer Inc and AstraZeneca’s vaccines, produced by Serum Institute in India, for emergency use on an accelerated basis.

But, these two aren’t the only one in the queue as Hyderabad-based Bharat Biotech has also applied for an emergency use authorisation for its investigational vaccine candidate, Covaxin, to the Indian regulator. The firm is conducting its Phase 3 trial, which involves 26,000 participants.

Tune in for more

Also Read

Coronavirus vaccine update: Brazil halts China jab trial on adverse effect

Coronavirus vaccine update: Brazil halts China jab trial on adverse effect

When will India finally have access to coronavirus vaccine?

When will India finally have access to coronavirus vaccine?

Coronavirus vaccine: How much it costs, who'll get it first and other FAQs

Coronavirus vaccine: How much it costs, who'll get it first and other FAQs

Covid vaccine updates: Key facts and major announcements you should know

Covid vaccine updates: Key facts and major announcements you should know

Coronavirus vaccine update: Mexico gets 1st doses of Chinese vaccine COVAX

Coronavirus vaccine update: Mexico gets 1st doses of Chinese vaccine COVAX

Topics :Coronavirus Vaccine Coronavirus Tests Pfizer Serum Institute of India

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 08 2020 | 12:20 PM IST